Seroprevalence of SARS-CoV-2 Among Adults in Three Regions of France Following the Lockdown and Associated Risk Factors: A Multicohort Study-Reference-Cited by-同舟云学术

Seroprevalence of SARS-CoV-2 Among Adults in Three Regions of France Following the Lockdown and Associated Risk Factors: A Multicohort Study

Published:2020 Issue: Volume: Page:
ISSN:1556-5068
Container-title:SSRN Electronic Journal
language:en
Short-container-title:SSRN Journal

Author:

Carrat Fabrice,de Lamballerie Xavier,Rahib Delphine,Blanché Hélène,Lapidus Nathanael,Artaud Fanny,Kab Sofiane,Renuy Adeline,de Edelenyi Fabien Szabo,Meyer Laurence,Lydié Nathalie,Charles Marie-Aline,Ancel Pierre-Yves,Jusot Florence,Rouquette Alexandra,Priet Stéphane,Villarroel Paola Mariela Saba,Fourié Toscane,Lusivika-Nzinga Clovis,Nicol Jerome,Legot Stephane,Druesne-Pecollo Nathalie,Esseddik Younes,Lai Cindy,Gagliolo Jean-Marie,Deleuze Jean-François,Bajos Nathalie,Severi Gianluca,Touvier Mathilde,Zins Marie,Groups SAPRIS and SAPRIS-SERO Study

Publisher

Elsevier BV

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systematic review of seroprevalence of SARS-CoV-2 antibodies and appraisal of evidence, prior to the widespread introduction of vaccine programmes in the WHO European Region, January–December 2020;BMJ Open;2023-11

2. Seroprevalence of SARS-CoV-2 antibodies among Forcibly Displaced Myanmar Nationals in Cox’s Bazar, Bangladesh 2020: a population-based cross-sectional study;BMJ Open;2022-11

3. Age-specific rate of severe and critical SARS-CoV-2 infections estimated with multi-country seroprevalence studies;BMC Infectious Diseases;2022-03-29

4. PREVALENCE OF MARKERS OF SARS-COV-2 INFECTION AMONG RESIDENTS OF KYIV REGION AT THE BEGINNING OF THE COVID-19 EPIDEMIC – FIRST RESULTS IN UKRAINE;JOURNAL OF THE NATIONAL ACADEMY OF MEDICAL SCIENCES OF UKRAINE;2021-08-30

5. Nationwide Seroprevalence of SARS-CoV-2 IgG Antibodies among Four Groups of Primary Health-Care Workers and Their Household Contacts 6 Months after the Initiation of the COVID-19 Vaccination Campaign in France: SeroPRIM Study Protocol;Pathogens;2021-07-20